Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer

An open-label, randomized phase II study of adecatumumab, a fully human anti-EpCAM antibody, as monotherapy in patients with metastatic breast cancer

(2009) M. Schmidt et al.   ANNALS OF ONCOLOGY

EpCAM, a human tumor-associated antigen promotes Th2 development and tumor immune evasion

(2009) A. Ziegler et al.   BLOOD

Coordinates in the Universe of Node-Negative Breast Cancer Revisited

(2009) M. Schmidt et al.   CANCER RESEARCH

Treatment of Malignant Pleural Effusion With the Trifunctional Antibody Catumaxomab (Removab) (Anti-EpCAM×Anti-CD3)

(2009) Martin Sebastian et al.   JOURNAL OF IMMUNOTHERAPY

Claudin-7 Regulates EpCAM-Mediated Functions in Tumor Progression

(2009) T. Nubel et al.   MOLECULAR CANCER RESEARCH

Therapeutic Window of MuS110, a Single-Chain Antibody Construct Bispecific for Murine EpCAM and Murine CD3

(2008) M. Amann et al.   CANCER RESEARCH

Subtypes of Breast Cancer Show Preferential Site of Relapse

(2008) M. Smid et al.   CANCER RESEARCH

The Humoral Immune System Has a Key Prognostic Impact in Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CANCER RESEARCH

Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer

(2008) M. Schmidt et al.   CLINICAL CANCER RESEARCH

Anti-Epithelial Cell Adhesion Molecule Antibodies and the Detection of Circulating Normal-Like Breast Tumor Cells

(2008) Anieta M. Sieuwerts et al.   JNCI-Journal of the National Cancer Institute